Menu
Recruiting NCT07467954

Comparative Effectiveness of Long-Pulsed 1064-nm Nd:YAG and Fractional CO₂ Laser in Skin Rejuvenation

No phase Interventional Skin Rejuvenation Laser

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Fractional CO₂ laser, Long-pulsed 1064-nm Nd:YAG laser.
Who it may be relevant to
Registry conditions: Skin Rejuvenation, Laser. Basic parameters: 30 years — 59 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Indonesia
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Comparative Split-Face Study of Long-Pulsed 1064-nm Nd:YAG and Fractional CO₂ Laser for Skin Rejuvenation Based on Dermal Thickness, Skin Elasticity, Wrinkle Assessment, and Global Aesthetic Improvement Scale Scores

Overview

Skin rejuvenation is an effort to improve skin condition from the signs of skin aging. Skin aging is a complex biological process influenced by intrinsic and extrinsic factors, leading to changes in the epidermis and dermis, including decreased collagen characterized by dermal thinning, as well as alterations in skin appearance such as laxity and wrinkles. Laser therapy is one of the treatment modalities for skin rejuvenation, aiming to induce neocollagenesis and collagen remodeling, resulting in dermal thickening and improvement in skin appearance. Fractional CO₂ laser is an ablative laser considered the gold standard therapy for skin rejuvenation, whereas Long Pulsed (LP) Nd:YAG 1064 nm is a nonablative laser that is also used for skin rejuvenation. To date, there have been no studies evaluating the comparative effectiveness between fractional CO₂ laser and LP Nd:YAG 1064 nm for skin rejuvenation. Therefore, research comparing the effectiveness of fractional CO₂ laser and LP Nd:YAG 1064 nm for skin rejuvenation is needed, assessed based on dermal thickness, skin elasticity, wrinkles, and Global Aesthetic Improvement Scale scores.

Interventions

  • Procedure Fractional CO₂ laser
    Fractional CO₂ laser was applied to one randomized side of the face in a split-face design for skin rejuvenation. Treatments were performed three times at one-month intervals. The laser delivers fractional ablative microthermal zones to stimulate dermal remodeling and collagen production. Treatment parameters were adjusted according to skin type and clinical indication.
  • Procedure Long-pulsed 1064-nm Nd:YAG laser
    Long-pulsed 1064-nm Nd:YAG laser was applied to the contralateral randomized side of the face in a split-face design for skin rejuvenation. Treatments were performed three times at one-month intervals. The laser delivers non-ablative dermal heating to stimulate collagen remodeling and improve skin texture and elasticity.

Primary outcome measures

  • Dermal Thickness [Time frame: From enrollment to the end of treatment at 20 weeks]
  • Skin Elasticity [Time frame: From enrollment to the end of treatment at 20 weeks]
  • Wrinkles [Time frame: From enrollment to the end of treatment at 20 weeks]
  • Global Aesthetic Improvement Scale Scores [Time frame: From enrollment to the end of treatment at 20 weeks]

Eligibility criteria

Inclusion criteria

  • Male and female patients with skin aging classified as Glogau scale II-III
  • Age 30-59 years.

Exclusion criteria

  • Pregnant or breastfeeding women.
  • Active smokers.
  • Individuals with high levels of sun exposure.
  • History of facial laser therapy, microdermabrasion, chemical peeling, botulinum toxin injection, microneedling, or skin booster injections within the past six months.
  • Use of oral isotretinoin within the past six months.
  • Use of topical retinoids or their derivatives, topical vitamin C, or other collagen-stimulating and skin-rejuvenating agents within the past two weeks.
  • Use of oral vitamin C, collagen-stimulating supplements, antioxidants, or hormone therapy with skin-rejuvenating effects within the past one month.
  • Presence of active facial skin inflammation.
  • History of keloid formation.
  • History of allergy to topical lidocaine anesthesia.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Indonesia · 1 center
  • Hasan Sadikin General Hospital — Bandung

Identifiers

NCT: NCT07467954 · DV-202603.01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗